Covista Inc. CVSA
120.75
(3.41)
(2.75%)
as of 25 Sep
- Market cap
- $4.2B
- P/E
- 16.8×
Follow CVSA
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
17.39 | 17.57 | 14.80 | 22.45 |
+8 more quarters Free account |
P/S ratio |
2.24 | 2.07 | 1.96 | 3.04 | |
P/FCF ratio |
11.12 | 11.50 | 9.85 | 16.87 | |
P/Operating CF |
35.24 | 21.22 | 124.28 | 42.72 | |
P/B ratio |
3.02 | 2.90 | 2.68 | 3.83 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
2.37 | 2.25 | 2.21 | 3.22 | |
EV/EBITDA |
9.75 | 9.45 | 9.15 | 13.17 | |
EV/Operating CF |
9.83 | 10.59 | 9.76 | 15.56 | |
EV/FCF |
11.77 | 12.52 | 11.13 | 17.85 | |
Quick Ratio |
0.97 | 0.56 | 0.50 | 0.80 | |
Current Ratio |
1.09 | 0.70 | 0.68 | 0.98 | |
Net Debt/EBITDA |
2.18 | 3.01 | 3.34 | 2.68 | |
Debt/Assets |
22.00% | 18.25% | 19.29% | 19.29% | |
Debt/Equity |
0.46 | 0.37 | 0.37 | 0.38 | |
Asset Turnover |
0.68 | 0.69 | 0.71 | 0.64 | |
Operating CF/Net income |
1.73 | 4.47 | 0.39 | 2.11 | |
Capex/Depreciation |
(1.24) | (0.80) | (0.65) | (0.75) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
37.51% | 37.80% | 36.31% | 38.01% | |
Intangible Assets out of Total Assets |
0.57 | 0.63 | 0.66 | 0.60 | |
Share Based Compensation of Revenue |
2.02% | 1.97% | 2.63% | 1.79% | |
Graham Net Nets |
(0.21) | (0.25) | (0.25) | (0.15) | |
Graham Number |
81.59 | 76.64 | 77.91 | 79.05 | |
Earnings Yield |
5.75% | 5.69% | 6.76% | 4.45% | |
Free Cash Flow Yield |
8.99% | 8.70% | 10.15% | 5.93% | |
Revenue per Share |
14.31 | 14.21 | 14.09 | 12.80 | |
Operating CF per Share |
3.54 | 5.43 | 0.83 | 3.62 | |
Capex per Share |
(0.77) | (0.59) | (0.41) | (0.44) | |
Free Cash Flow per Share |
2.77 | 4.84 | 0.42 | 3.17 | |
Cash per Share |
11.64 | 4.34 | 1.64 | 7.37 | |
Shareholders Equity per Share |
41.27 | 39.79 | 38.59 | 40.37 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
41.27 | 39.79 | 38.59 | 40.37 | |
Free Cash Flow |
97.15 | 165.93 | 15.12 | 114.53 | |
Working Capital |
55.62 | (176.69) | (139.90) | (9.40) | |
Capital Expenditures |
(26.81) | (20.23) | (14.62) | (16.02) | |
Net Current Asset Value |
(914.08) | (969.57) | (932.93) | (842.62) | |
EV/EBIT |
12.06 | 11.79 | 11.48 | 16.54 | |
Capex to Sales |
0.05 | 0.04 | 0.03 | 0.03 | |
Net Profit Margin |
14.30% | 8.55% | 15.17% | 13.38% | |
Price to Operating Income |
11.40 | 10.83 | 10.15 | 15.63 | |
| Other line items | |||||
Average Receivables |
157.88 | 169.45 | 154.91 | 183.17 | |
Average Payables |
114.89 | 97.99 | 85.01 | 98.00 | |
Average Assets |
2,882.53 | 2,763.59 | 2,668.83 | 2,842.59 | |
Average Common Equity |
1,439.91 | 1,398.41 | 1,408.85 | 1,423.79 |
Columns are period end dates